ホーム > 市場調査レポート > Custom Synthesis Business for Life Science Industries in Japan
A comprehensive study of the pharmaceutical material industry focusing on 38 selected chemical companies
Custom Synthesis Business for Life Science Industries in Japan
レポート概要
Comprehensive study was carried out in order to provide deep insights into the strategic business of active ingredients and intermediates manufacturers in Japan - from medium- to large-scale companies - offering custom synthesis services to leading international pharmaceutical companies.
Technological competence as well as both current and potential production capacities of each company are highlighted, with a particular focus on their competitiveness in the international market in terms of cost, product quality, environmental impact, and strengths in organic synthesis, biosynthesis and combined technology to manufacture chiral compounds.
The Product Lists contain specific types of custom synthesis being made available from each company surveyed, along with chemical structure of the compounds, pharmaceutical companies using those substances, and the drugs for which those materials are used.
Technological competence as well as both current and potential production capacities of each company are highlighted, with a particular focus on their competitiveness in the international market in terms of cost, product quality, environmental impact, and strengths in organic synthesis, biosynthesis and combined technology to manufacture chiral compounds.
The Product Lists contain specific types of custom synthesis being made available from each company surveyed, along with chemical structure of the compounds, pharmaceutical companies using those substances, and the drugs for which those materials are used.
| レポート名 | Custom Synthesis Business for Life Science Industries in Japan |
| 発刊日 | 2003年07月03日 |
| 体裁 | A4 / 269ページ |
| 販売価格 | 210,000円（本体価格200,000円、消費税10,000円） |
| 発行 | 株式会社シード・プランニング |
| 備考 | $ 1,995 for orders from outside Japan |
| 関連カテゴリ | 医薬原料・製剤メーカー |
レポート詳細
Companies surveyed
Ajinomoto Co., Inc. API Corporation Asahi Glass Co., Ltd. Central Glass Co.,Ltd. Chisso Corporation Daicel Chemical Industries, Ltd. Daiichi Fine Chemicals Co., Ltd. Daikin Industries, Ltd. Daiso Co., Ltd. Hokko Chemical Industry Co., Ltd. Ihara Chemical Industry Co., Ltd. Kaneka Chemical Industry, Co. Ltd. Koei Chemical Co., Ltd. Kuraray Co., Ltd. Kyowa Hakko Kogyo Co., Ltd. Mercian Corporation Mitsubishi Rayon Co., Ltd. Mitsui Chemicals, Inc. New Japan Chemical Co., Ltd. Nissan Chemical Industries.,Ltd. Nippon Fine Chemical Co., Ltd. Nippon Kayaku Co., Ltd. Nippon Nohyaku Co., Ltd. Nippon Shokubai Co., Ltd. Nippon Soda Co., Ltd. Nisshin Pharma Inc. Otsuka Chemical Co., Ltd. Shin-Etsu Chemical Co., Ltd. Soda Aromatic Co., Ltd. Sumika Fine Chemicals Co., Ltd. Sumikin Air Water Chemical Inc. Sumitomo Chemical Co., Ltd. Sumitomo Seika Chemicals Co., Ltd. Takasago International Corp. Tosoh Corporation The Nippon Synthetic Chemical Industry Co., Ltd. Ube Industries, Ltd. Yuki Gosei Kogyo Co., Ltd.The contents
- 1. Introduction
- 2. Summary
- 3. Case study (38 medium to large selected companies)
-
Headquarters
- Contact
- Founded
- Capital
- Employees
- Major shareholders
- Performance for Fiscal 2002: Non-consolidated (consolidated)
-
- Total sales
- R&D expenditures
- Net income
- Total asset
- Cash flow from operational activities
- Performance data by business/activity
- Core products and technologies related to pharmaceuticals
- Subsidiaries and affiliates related to pharmaceuticals (% invested)
Areas of Competence
Factories and Major Facilities
- Plant
-
- 1) Custom synthesis (cGMP-compliant)
- 2) Pilot facilities
- 3) Investigational drug production facilities
